GUT REPRINT
LIVE

Serial Number

79211794

Owner

MAAT PHARMA

Attorney

Jeffrey H. Greger

Filing Date

Mar 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

GUT REPRINT Trademark

Serial Number: 79211794 • Registration: 5472077

GUT REPRINT is a trademark filed by MAAT PHARMA on March 28, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

MAAT PHARMA (12 trademarks)

70 avenue Tony Garnier

Entity Type: 99

Trademark Details

Filing Date

March 28, 2017

Registration Date

May 22, 2018

Published for Opposition

March 6, 2018

Cancellation Date

December 6, 2024

Goods & Services

Surgical apparatus and instruments; medical apparatus and instruments, namely, medical apparatus used in stools manipulation, including for the collection, transformation and/or final delivery of the obtained fecal drug product; veterinary apparatus and instruments, namely, medical apparatus used in stools manipulation, including for the collection, transformation and/or final delivery of the obtained fecal drug product; medical apparatus for fecal transplantation for restoring the intestinal microbiota; diagnostic apparatus for medical use, namely, diagnostic apparatus for medical diagnostic testing in the field of gut microbiota related diseases; testing apparatus for medical use, namely, apparatus for medical diagnostic testing in the field of gut dysbiosis related diseases; intestinal microbiota analysis apparatus for medical use; blood testing apparatus; hypogastric belts for medical purposes; dialyzers; drainage tubes for medical use; gastroscopes; abdominal pads; fluid injectors for medical use, sold empty; enema apparatus for medical use; artificial limbs, eyes and teeth; orthopedic articles, namely, devices for therapeutic use; suture material

Pharmaceutical products and veterinary preparations for the treatment of gut dysbiosis related diseases; human medicines for the treatment of gut dysbiosis related diseases; chemical preparations for medical, pharmaceutical or veterinary use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely microbiotherapy preparations for intestinal microbiome repair; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely, for the treatment of gut dysbiosis related diseases; enzyme preparations for medical or veterinary use; culture media for bacteriology; chemico-pharmaceutical products, namely, chemical preparations for pharmaceutical purposes for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair; stem cells for medical or veterinary use; cultures of microorganisms and biological tissues for medical or veterinary use; diagnostic preparations for medical use; digestives for pharmaceutical use; ferments for pharmaceutical use; preparations for medical use for fecal transplantation for restoring the intestinal microbiota; sanitary preparations for medical purposes; dietetic food and dietetic beverages adapted for medical or veterinary use, food for babies; food supplements for humans and animals; medical plasters, materials for dressings, namely, lint for medical purposes; material for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides, herbicides

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 6, 2026 INTS
INVALIDATION PROCESSED
Mar 6, 2026 INPC
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 6, 2025 INTR
CANCELLED SECTION 71
Dec 6, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 9, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 7, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 7, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 22, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 22, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Mar 9, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2018 NONP
ASSIGNED TO LIE
Jan 28, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 18, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 18, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 18, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 18, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 11, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 17, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 15, 2017 MAFR
ASSIGNED TO EXAMINER
Jul 11, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2017 REPR